Utilization of Bioimpedance Spectroscopy in the Prevention of Chronic Breast Cancer-Related Lymphedema

Written by admin
December 25, 2017

Breast cancer represents the most common non-cutaneous malignancy for women in the United States with over 250,000 new cases diagnosed each year. With improved outcomes, the number of breast cancer survivors is growing dramatically. As a result, a significant number of women are dealing with the potential acute, sub-acute, and chronic toxicities of treatment including breast cancer-related lymphedema (BCRL). Read More...


Category: Uncategorized


Leave a Reply